UT-Southwestern Medical Center: Lung Cancer Treatment Shows Promise in Tumor Models
March 12, 2024
March 12, 2024
DALLAS, Texas, March 12 (TNSres) -- The University of Texas Southwestern Medical Center issued the following news release:
A molecule has demonstrated its ability to kill tumor cells and incite an immune response in preclinical models of small cell lung cancer (SCLC), according to UT Southwestern Medical Center researchers. The findings, published in Nature Communications, could lead to more successful treatments for SCLC, one of the leading causes of cancer-related deaths in the U. . . .
A molecule has demonstrated its ability to kill tumor cells and incite an immune response in preclinical models of small cell lung cancer (SCLC), according to UT Southwestern Medical Center researchers. The findings, published in Nature Communications, could lead to more successful treatments for SCLC, one of the leading causes of cancer-related deaths in the U. . . .